Success Stories: Our Assiduous Team Assisted A Postdoctoral Scholar from South Africa to Attain EB-2 NIW Approval

 

Client’s Testimonial:

“It was a pleasure to work with Chen Immigration. They only required me to upload two documents on my work and from there they drafted a very strong case and recommendation letters. I am so glad I retained them as it was an easy and effortless process on my part. I highly recommend them for employment-based immigration, they are simply the best in the business.”


On May 18th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Scholar in the Field of Pharmacology (Approval Notice).


General Field: Pharmacology

Position at the Time of Case Filing: Postdoctoral Scholar

Country of Origin: South Africa

State of Residence at the Time of Filing: California

Approval Notice Date: May 18th, 2021

Processing Time: 7 months, 18 days


Case Summary:

North America Immigration Law Group was engaged by a postdoctoral scholar to assist her in documenting an EB-2 NIW (National Interest Waiver) petition on her behalf. With a Ph.D. in chemistry and researching the field of pharmacology, our client displayed all the expected skill sets to secure the national interest waiver. As a segment of our legal services, we evaluated her credentials and made sure of the provided relevant documents to be presented to the USCIS. After the assessment, we organized an influential petition packet with the below-mentioned data:

  • Essentially, we described her research into translational models of novel antibiotic drugs with a focus on preventing resistance to provide a drug discovery and development platform that optimizes antibiotics, provides safe and effective doses, and targets unique subpopulations of patients. We deduced that the research in her area is of great importance because the need to bring novel anti-infective drugs to market is increasing alongside upward trends in antibiotic resistance.
  • We also detailed the 64 citations garnered from the 7 peer-reviewed journal articles (3 of them first- or co-first-authored) and 1 abstract she published. Moreover, our client’s research was supported through grants and received funding from many globally significant federal organizations and nonprofit agencies, signifying the overarching value of her endeavors.
  • Additionally, we added five recommendation letters that she obtained from fellow proficient researchers in the field, confirming that our client’s success is clearly the product of superior education and substantial contributions to advances in the field of pharmacology. One of the recommenders contributed the below-stated:
“[Client] specializes, will drive nearly a quarter of this growth. Considering personalized medicine not only represents the next frontier of medical care in the United States but is also revolutionizing the way drugs are developed, tested, and prescribed, it is more crucial than ever to retain exceptional scientists like her.”

USCIS thoroughly adjudicated her work, and she triumphantly achieved her EB-2 NIW approval within 7 months 18 days without an RFE (request for evidence). We had the pleasure of assisting her, and we would like to thank her for collaborating with us. We also congratulate her on this milestone.